作者
Dimitris Tousoulis, Evangelos Oikonomou, Evangelos K Economou, Filippo Crea, Juan Carlos Kaski
发表日期
2016/6/7
来源
European heart journal
卷号
37
期号
22
页码范围
1723-1732
出版商
Oxford University Press
简介
The notion of atherosclerosis as a chronic inflammatory disease has intensified research on the role of cytokines and the way these molecules act and interact to initiate and sustain inflammation in the microenvironment of an atherosclerotic plaque. Cytokines are expressed by all types of cells involved in the pathogenesis of atherosclerosis, act on a variety of targets exerting multiple effects, and are largely responsible for the crosstalk among endothelial, smooth muscle cells, leucocytes, and other vascular residing cells. It is now understood that widely used drugs such as statins, aspirin, methotrexate, and colchicine act in an immunomodulatory way that may beneficially affect atherogenesis and/or cardiovascular disease progression. Moreover, advancement in pharmaceutical design has enabled the production of highly specific antibodies against key molecules involved in the perpetuation of the inflammatory …
引用总数
201620172018201920202021202220232024194342546182735548
学术搜索中的文章